Expression of selected epithelial–mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers

Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers

(2017) Pawel Sadlecki et al.   TUMOR BIOLOGY

Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications

(2016) Silvia Juliana Serrano-Gomez et al.   Molecular Cancer

Epithelial-mesenchymal interconversions and the regulatory function of the ZEB family during the development and progression of ovarian cancer

(2016) DI WU et al.   Oncology Letters

MicroRNA Regulation of Epithelial to Mesenchymal Transition

(2016) Mohammed Abba et al.   Journal of Clinical Medicine

Controversies in borderline ovarian tumors

(2015) Seok Ju Seong et al.   Journal of Gynecologic Oncology

Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention

(2014) Samantha Kaufhold et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The Role of TWIST in Ovarian Epithelial Cancers

(2014) Kyungbin Kim et al.   Korean Journal of Pathology

Molecular mechanisms of epithelial–mesenchymal transition

(2014) Samy Lamouille et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Evaluation of the mechanism of epithelial-mesenchymal transition in human ovarian cancer stem cells transfected with a WW domain-containing oxidoreductase gene

(2014) HONGCHAO YAN et al.   Oncology Letters

The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer

(2014) Masaaki Takai et al.   Journal of Ovarian Research

The Role of Nuclear β-Catenin Accumulation in the Twist2-Induced Ovarian Cancer EMT

(2013) Yubin Mao et al.   PLoS One

Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen

(2012) A. Prat et al.   ANNALS OF ONCOLOGY

Mechanisms of Ovarian Cancer Metastasis: Biochemical Pathways

(2012) Kentaro Nakayama et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

(2012) Jaime Prat   VIRCHOWS ARCHIV

Epithelial–Mesenchymal Transition in Ovarian Carcinoma

(2012) Ben Davidson et al.   Frontiers in Oncology

Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells

(2011) J-C Cheng et al.   ONCOGENE

The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

(2010) Robert J. Kurman et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition

(2010) Muh-Hwa Yang et al.   NATURE CELL BIOLOGY

Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin

(2010) J-C Cheng et al.   ONCOGENE

Ovarian Low-grade and High-grade Serous Carcinoma

(2009) Russell Vang et al.   ADVANCES IN ANATOMIC PATHOLOGY

Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression

(2009) Hanna Tuhkanen et al.   BMC CANCER

Epithelial–mesenchymal transition in ovarian cancer

(2009) Daniele Vergara et al.   CANCER LETTERS

TGF-β-induced epithelial to mesenchymal transition

(2009) Jian Xu et al.   CELL RESEARCH

Cadherin switching

(2008) M. J. Wheelock et al.   JOURNAL OF CELL SCIENCE

Direct regulation of TWIST by HIF-1α promotes metastasis

(2008) Muh-Hwa Yang et al.   NATURE CELL BIOLOGY

Epithelial–mesenchymal transition and the invasive potential of tumors

(2008) Nancy Gavert et al.   TRENDS IN MOLECULAR MEDICINE